Circulating Cell-Free DNA as a Biomarker for Prognosis and Response to Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma

医学 生物标志物 内科学 肝细胞癌 危险系数 肿瘤科 全身疗法 胎儿游离DNA 比例危险模型 置信区间 癌 胃肠病学 癌症 乳腺癌 生物 胎儿 生物化学 遗传学 产前诊断 怀孕
作者
Takuya Watanabe,Yuji Suzuki,Hidekatsu Kuroda,Hayato Hiraki,Akiko Suzuki,Akio Tamura,Yoshiro Ieko,Satoshi Nishizuka,Takayuki Matsumoto
出处
期刊:Oncology [Karger Publishers]
卷期号:101 (11): 714-722 被引量:2
标识
DOI:10.1159/000531671
摘要

Systemic therapy provides clinical benefits to a subset of patients with advanced unresectable hepatocellular carcinoma (HCC). However, few biomarkers are available for predicting prognosis and treatment response in patients with advanced HCC undergoing treatment with systemic therapies. This study aimed to examine whether circulating cell-free DNA (cfDNA) containing circulating tumor DNA can act as a therapeutic response and prognostic biomarker in patients with advanced HCC.We analyzed longitudinally collected plasma cfDNA of patients with advanced HCC who were naïve to systemic therapy, and assessed their prognostic and predictive values to determine treatment responses.cfDNA concentration positively correlated with entire tumor volume on computed tomography before (p = 0.0231) and at the end (p < 0.0001) of the first-line systemic therapy. The overall survival rate was higher in patients with cfDNA concentrations lower than the median cfDNA level at baseline compared to patients with higher cfDNA concentrations (hazard ratio, 0.2765; 95% confidence interval, 0.08-0.81; p = 0.0197). The ratio of cfDNA at 4 weeks to that at baseline was predictive of radiographic disease response. In patients with progressive disease, cfDNA concentration at 4 weeks increased significantly (p = 0.0245), whereas the concentration remained unchanged in patients with other disease courses (p = 0.9375).The baseline plasma cfDNA concentration can be used as a prognostic biomarker in patients with advanced HCC. cfDNA kinetics may also predict the tumor response to therapy and disease progression.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的铭的应助被科研通管家采纳,获得10
1秒前
风吹麦浪的应助被科研通管家采纳,获得10
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
风吹麦浪的应助被科研通管家采纳,获得10
1秒前
风吹麦浪的应助被科研通管家采纳,获得10
1秒前
风吹麦浪的应助被科研通管家采纳,获得10
1秒前
风吹麦浪的应助被科研通管家采纳,获得10
1秒前
聪慧的小馒头完成签到,获得积分10
1秒前
慕青的应助被科研通管家采纳,获得10
1秒前
所所的应助被科研通管家采纳,获得10
2秒前
SciGPT的应助被科研通管家采纳,获得10
2秒前
余香的应助被科研通管家采纳,获得10
2秒前
完美世界的应助被科研通管家采纳,获得10
2秒前
wanci的应助被科研通管家采纳,获得10
2秒前
2秒前
顾矜的应助被科研通管家采纳,获得10
2秒前
852的应助被科研通管家采纳,获得10
2秒前
Ava的应助被科研通管家采纳,获得10
2秒前
海宁完成签到,获得积分10
3秒前
英姑的应助被科研通管家采纳,获得10
3秒前
领导范儿的应助被科研通管家采纳,获得10
3秒前
3秒前
脑洞疼的应助被科研通管家采纳,获得10
3秒前
英姑的应助被科研通管家采纳,获得10
3秒前
Lucas的应助被科研通管家采纳,获得10
3秒前
搜集达人的应助被科研通管家采纳,获得10
3秒前
斯文败类的应助被科研通管家采纳,获得10
3秒前
我是老大的应助被科研通管家采纳,获得10
4秒前
4秒前
Owen的应助被科研通管家采纳,获得10
4秒前
4秒前
852的应助被科研通管家采纳,获得10
4秒前
Maestro_S的应助被科研通管家采纳,获得10
4秒前
大模型的应助被科研通管家采纳,获得10
4秒前
Lucia完成签到 ,获得积分10
4秒前
Orange的应助被无私藏鸟采纳,获得10
4秒前
李健的应助被科研通管家采纳,获得30
4秒前
无极微光的应助被花花采纳,获得20
4秒前
5秒前
香蕉觅云的应助被科研通管家采纳,获得10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190724
求助须知:如何正确求助?哪些是违规求助? 9577784
关于积分的说明 21855018
捐赠科研通 7789883
什么是DOI,文献DOI怎么找? 3436455
关于科研通互助平台的介绍 2560308
邀请新用户注册赠送积分活动 2483172